Lauren M. Corduck, Founder Oneinforty

A person with short gray hair and light skin is smiling at the camera. They are wearing a blue and white patterned top and a silver necklace. The background is blurred with greenery visible.

In late 2016 at the age of 45, Lauren sought genetic counseling and screening on a friend’s urging. The screening–a simple blood test–showed that she had inherited a mutation in her BRCA1 gene from her father, putting her at much higher risk than the general population of developing breast and ovarian cancer.

Lauren’s genetic counselor advised her to have, surgery that would have dramatically reduced her risk of developing ovarian cancer. But it was too late. Around the same time, Lauren had an MRI of her back to determine the cause of severe back pain she had been experiencing. The MRI revealed an incidental finding of what turned out to be Stage 4 ovarian cancer that had metastasized to lymph nodes.

A woman sitting in a chair holds a framed photo of a bride in a wedding dress, while a man stands behind her with his hand on her shoulder. They are indoors, surrounded by plants and modern furniture.

Six adults stand in a circle, looking down toward the camera and smiling. The photo is taken from below, creating a circular composition with their faces around the edge.

Given her family history of breast cancer and her Ashkenazi Jewish heritage, Lauren should have been referred to a genetic counselor and screened for the BRCA gene mutations many years ago. If she had, she would have learned of the mutation earlier, when interventions could have made a difference.

While undergoing cancer treatment, Lauren discovered that most American Jews of eastern and central European descent, like her, are not aware of the one-in-forty chance of having a mutation in their BRCA1 or BRCA2 gene that puts them at much higher risk than the general population of developing ovarian cancer, breast cancer (male or female), and/or prostate cancer.

She set out on a mission to educate the community, healthcare providers, and policy makers about the one-in-forty risk to the Ashkenazi Jewish population of inheriting a BRCA gene mutation, because she wanted to help families avoid the situation she and her family found themselves in. If Lauren had known about her BRCA status earlier in life, she may have been able to prevent or identify the cancer earlier.

Seven women stand side by side in a meeting room, smiling at the camera. Behind them, a computer screen displays a website with text and images. Some women wear ID badges, and a table is partially visible in front.
Four women stand and sit behind a table covered with oneinforty banners. The table displays brochures, pens, and information materials about BRCA awareness, education, and support.

In late 2020, after years of treatments, Lauren, just 49 years old, passed away peacefully. Lauren was compassionate, giving, smart, fierce, generous, loving, and showed us all that with determination and action you can make a difference.

We continue to honor Lauren and the countless families impacted by hereditary cancer by fulfilling Lauren’s mission to stop BRCA-related cancer in its tracks.

Make a Donation in Lauren’s Memory